Healthcare provider profile · identity verified

Karen E Bruce, MD

Family Practice · TOPEKA, KS · NPI 1831298462

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	318	93
Atorvastatin Calcium	Atorvastatin Calcium	272	82
Lisinopril	Lisinopril	245	74
Simvastatin	Simvastatin	220	67
Amlodipine Besylate	Amlodipine Besylate	201	69
Omeprazole	Omeprazole	198	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	189	46
Losartan Potassium	Losartan Potassium	177	55
Pantoprazole Sodium	Pantoprazole Sodium	135	43
Gabapentin	Gabapentin	134	40
Metoprolol Succinate	Metoprolol Succinate	127	34
Duloxetine Hcl	Duloxetine Hcl	109	22
Hydrochlorothiazide	Hydrochlorothiazide	107	38
Tramadol Hcl	Tramadol Hcl	107	31
Fluticasone Propionate	Fluticasone Propionate	101	28
Metformin Hcl	Metformin Hcl	98	29
Rosuvastatin Calcium	Rosuvastatin Calcium	95	28
Potassium Chloride	Potassium Chloride	90	32
Bupropion Xl	Bupropion Hcl	89	22
Tamsulosin Hcl	Tamsulosin Hcl	86	22
Montelukast Sodium	Montelukast Sodium	83	25
Albuterol Sulfate Hfa	Albuterol Sulfate	79	34
Donepezil Hcl	Donepezil Hcl	78	17
Metoprolol Tartrate	Metoprolol Tartrate	76	20
Sertraline Hcl	Sertraline Hcl	74	26
Trazodone Hcl	Trazodone Hcl	74	27
Tizanidine Hcl	Tizanidine Hcl	70	19
Famotidine	Famotidine	65	14
Furosemide	Furosemide	64	20
Allopurinol	Allopurinol	63	16
Clopidogrel	Clopidogrel Bisulfate	63	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	12
Pregabalin	Pregabalin	60	16
Eliquis	Apixaban	59	12
Morphine Sulfate Er	Morphine Sulfate	59	11
Pravastatin Sodium	Pravastatin Sodium	57	18
Zolpidem Tartrate	Zolpidem Tartrate	57	19
Finasteride	Finasteride	53	15
Spironolactone	Spironolactone	50	13
Atenolol	Atenolol	47	14
Metformin Hcl Er	Metformin Hcl	47	12
Oxycodone Hcl	Oxycodone Hcl	46	13
Clonazepam	Clonazepam	45	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	11
Meloxicam	Meloxicam	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	17
Ozempic	Semaglutide	44	11
Venlafaxine Hcl Er	Venlafaxine Hcl	42	11
Ezetimibe	Ezetimibe	40	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Tolterodine Tartrate Er	Tolterodine Tartrate	39	suppressed
Alprazolam	Alprazolam	38	suppressed
Celecoxib	Celecoxib	38	suppressed
Estradiol	Estradiol	37	12
Glipizide	Glipizide	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	12
Carvedilol	Carvedilol	32	12
Glimepiride	Glimepiride	32	suppressed
Synthroid	Levothyroxine Sodium	30	11
Farxiga	Dapagliflozin Propanediol	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	12
Levetiracetam	Levetiracetam	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Linzess	Linaclotide	22	suppressed
Baclofen	Baclofen	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Diazepam	Diazepam	19	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Prednisone	Prednisone	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Topiramate	Topiramate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error